ImmunoGen (IMGN) Q1 2022 Earnings Call Transcript

IMGN earnings call for the period ending March 31, 2022.

Related Keywords

China ,Beijing ,Shanghai ,Russia ,Huadong ,Guangdong ,Ukraine ,Mark Enyedy ,Andy Hsieh ,Joe Catanzaro ,John Newman ,Jessica Fye ,Etzer Darout ,Andy Hsieh William Blair ,Joe Catanzaro Piper Sandler ,Kristen Harrington Smith ,Piper Sandler ,Anna Berkenblit ,Michael Schmidt Guggenheim ,Kelly Shi Jefferies ,Jonathan Chang ,John Newman Canaccord Genuity ,Dsusan Altschuller ,Courtney Okonek ,Michael Schmidt ,Kelly Shi ,William Blair ,Company Analyst ,Courtneyo Konek ,Risk Factors ,Chief Executive ,Molecular Cancer Therapeutics ,Market Access Strategy ,Huadong Medicine ,Boris Peaker ,Guggenheim Securities ,